Company Filing History:
2 out of 531 
1 out of 3 Years Active: 2016
Title: Michiel Stork: Innovator in Vaccine Development
Introduction
Michiel Stork is a prominent inventor based in Utrecht, Netherlands. He has made significant contributions to the field of vaccine development, particularly in the treatment and prevention of Gram-negative bacterial infections. With a total of two patents to his name, Stork's work is recognized for its innovative approaches to immunogenic compositions.
Latest Patents
Stork's latest patents include compositions and methods for the treatment or prevention of Gram-negative bacterial strain infections. These patents provide methods for the manufacture of said compositions. Another notable invention relates to immunogenic compositions comprising neisserial blebs with upregulated levels of the NMB0964 antigens. This invention aims to generate bacterial antibodies against the antigen. Methods to upregulate expression through the removal of the zinc repression mechanism of the cell or promoter, or through the removal of zinc from the culture medium, are also included.
Career Highlights
Throughout his career, Michiel Stork has worked with esteemed organizations such as GlaxoSmithKline Biologicals and Utrecht University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Stork has collaborated with notable colleagues, including Jan Poolman and Johannes Petrus Maria Tommassen. These collaborations have fostered a productive environment for innovation and research in vaccine development.
Conclusion